New Ontario institute focuses on chronic disease and ageing
Let’s face it – Ontario has a large ageing population. Unfortunately, that fact often comes hand-in-hand with the overwhelming cost of managing chronic and degenerative conditions, such as muscular dystrophy and other neuromuscular disorders.
Fortunately, Ontario also happens to be a leader in regenerative medicine research. To support advances in this field and to address the staggering healthcare expenses affecting Ontario’s aging population, the Government of Ontario is funding the new Ontario Institute for Regenerative Medicine (OIRM) – a research and development institute developed to help transform stem cell research into curative therapies for major degenerative diseases.
The goal of this collaborative initiative between the Ontario Stem Cell Initiative (OSCI) and the Centre for Commercialization of Regenerative Medicine (CCRM) is to help treat, manage and work towards finding a cure for some of the world’s most devastating disorders, all the while offering significant economic benefits.
OSCI brings together a team of accomplished stem cell researchers, tissue engineers and clinicians, while CCRM’s commercialization focus and strong network of industry partners will help facilitate academic discoveries and clinical trials.
What is meant by regenerative medicine? This is a multidisciplinary approach that harnesses the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs.
Stem cells were first discovered in Ontario and this new institute will help reinforce Ontario’s leadership position in regenerative medicine, says Janet Rossant, Interim Director of the OIRM.
“Ontario is the birthplace of stem cell discovery – it’s wonderful to be able to continue this legacy.”
Please see this press release for more information: http://ontariostemcell.ca/sites/default/files/ontario-supporting-groundbreaking-stem-cell-research-1.htm